Q3
LONG ANSWER
10M
★ High-yield
Describe the de novo synthesis of fatty acids. Explain the citrate shuttle, the role of acetyl-CoA carboxylase, and compare it with β-oxidation.
Definition and Site
De novo lipogenesis = synthesis of fatty acids from acetyl-CoA, yielding palmitate (C16) as the primary product.
| Feature | Detail |
|---|---|
| Site (cell) | Cytosol |
| Site (tissue) | Liver (chief), adipose tissue, lactating mammary gland, kidney |
| When | Fed state, carbohydrate excess |
| Reducing agent | NADPH |
| Product | Palmitate |
Transport of Acetyl-coa — the Citrate Shuttle
- Acetyl-CoA is made in the mitochondrion but needed in the cytosol, and cannot cross the inner membrane
Acetyl-CoA + oxaloacetate → citrate (citrate synthase) → Citrate crosses via the tricarboxylate carrier → In cytosol: ATP-citrate lyase → Acetyl-CoA + oxaloacetate → OAA → malate → malic enzyme → pyruvate + NADPH → Pyruvate returns to the mitochondrion
- The shuttle also generates NADPH through the malic enzyme — a second purpose
- Citrate accumulates only when the cell has plenty of energy, so it is a natural signal that lipogenesis is appropriate
The Committed Step — Acetyl-coa Carboxylase
Acetyl-CoA + CO2 + ATP → malonyl-CoAEnzyme: acetyl-CoA carboxylase; coenzyme: biotin
| Regulation | Effect |
|---|---|
| Citrate | Activates (allosteric; polymerises the enzyme) |
| Palmitoyl-CoA | Inhibits (feedback) |
| Insulin | Activates (dephosphorylation); also induces the enzyme |
| Glucagon, adrenaline | Inhibit (phosphorylation via AMPK) |
- This is the rate-limiting and committed step of fatty acid synthesis
- Malonyl-CoA inhibits CPT-I, shutting down β-oxidation at the same time — reciprocal control from a single molecule
Fatty Acid Synthase Complex
- A dimer, each monomer carrying seven enzyme activities plus acyl carrier protein (ACP)
- ACP contains phosphopantetheine, derived from pantothenic acid (B5)
- The growing chain remains bound throughout — no free intermediates escape
The repeating sequence
Condensation — acetyl + malonyl, CO2 released → Reduction — NADPH → Dehydration → Reduction — NADPH → Chain now 2 carbons longer; repeat 7 times
- After 7 cycles, thioesterase releases palmitate
- The CO2 fixed by carboxylase is released again at condensation — it is catalytic, driving the reaction forward
Stoichiometry and Sources of Nadph
8 Acetyl-CoA + 7 ATP + 14 NADPH → Palmitate
| Source of NADPH | Contribution |
|---|---|
| HMP (pentose phosphate) shunt | The chief source |
| Malic enzyme | Within the citrate shuttle |
| Cytosolic isocitrate dehydrogenase | Minor |
Comparison with Β-oxidation
| Feature | Synthesis | β-Oxidation |
|---|---|---|
| Site | Cytosol | Mitochondrial matrix |
| Carrier | ACP | Coenzyme A |
| Coenzyme | NADPH | NAD+ and FAD |
| 2-carbon unit | Malonyl-CoA | Acetyl-CoA |
| Bicarbonate / biotin | Required | Not required |
| Regulated by | Acetyl-CoA carboxylase | CPT-I |
| Hormone | Insulin | Glucagon |
| Energy | Consumes | Yields |
Elongation and Desaturation
- Elongation occurs in the endoplasmic reticulum (malonyl-CoA, NADPH) and in mitochondria (acetyl-CoA)
- Desaturation by Δ9, Δ6 and Δ5 desaturases in the ER
- Man cannot introduce a double bond beyond carbon 9 — which is why linoleic and α-linolenic acids are essential and must come from the diet
Applied Aspects
- Excess carbohydrate is converted to fat — the biochemical basis of obesity from a high-carbohydrate diet
- Non-alcoholic fatty liver disease — excess hepatic lipogenesis, driven by insulin resistance and fructose, is central to its pathogenesis
- Biotin deficiency impairs acetyl-CoA carboxylase and therefore lipogenesis
- Metformin activates AMPK → inhibits acetyl-CoA carboxylase → ↓ lipogenesis and ↑ fat oxidation
- Fatty acid synthase is over-expressed in many tumours and is being explored as a drug target
All questions in Lipid Metabolism
- Q1Describe the β-oxidation of fatty acids. Explain the carnitine shuttle, the energetics for palmitate, and the regulation of the pathway. ★
- Q2Describe the synthesis and utilisation of ketone bodies. Explain the causes of ketosis and the biochemical basis of diabetic ketoacidosis. ★
- Q3Describe the de novo synthesis of fatty acids. Explain the citrate shuttle, the role of acetyl-CoA carboxylase, and compare it with β-oxidation. ★
- Q4Describe the biosynthesis and regulation of cholesterol. Give its functions, transport and fate. Add a note on hypercholesterolaemia. ★
- Q5Classify the plasma lipoproteins. Describe their metabolism and the role of apolipoproteins. Add a note on the hyperlipoproteinaemias. ★
- SN1Describe the carnitine shuttle and its regulation. ★
- SN2Define fatty liver. Describe its causes and mechanisms. Add a note on lipotropic factors. ★
- SN3Define essential fatty acids. Give their sources, functions and the features of deficiency. ★
- SN4Describe the synthesis and actions of the eicosanoids. Explain the action of aspirin. ★
- SN5Describe lipoprotein lipase with its site, activator and significance.
- SN6Classify phospholipids and describe their functions. Add a note on lung surfactant. ★
- SN7Describe the biochemical basis of atherosclerosis and the lipid risk factors. ★